Atlas Trials

Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide

Clinical trial NCT06497595 · RECRUITING

Trial details

NCT number
NCT06497595
Sponsor
Sheba Medical Center
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus in Obese
Start date
2025-05-11
Primary completion
2027-09-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.